This PharmaPhorum article, highlights a report commissioned by NHS Digital that states that products based on artificial intelligence should be regulated like drugs, and those that are deemed unsafe should be removed from the market.
The report goes on to say that AI-based products are likely to fall under the remit of the UK’s regulator, the Medicines and Healthcare products Regulatory Agency (MHRA).
But they will also have implications for other organisations, according to the report from the Academy of Medical Royal Colleges, Artificial Intelligence in Healthcare, who investigated the clinical, ethical and practical issues of using the technology in the NHS.
Other organisations affected will be the medical regulator, the General Medical Council, which will need to give clear guidelines on appropriate use of AI.
Medical defence organisations may need to be prepared given the increasing number of patients given AI-generated decisions and recommendations.